SCHEMBL1270136

SCHEMBL1270136

CC(C)(C)c1nc(N)c2c(-c3ccc(Cl)cc3)n[nH]c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.44
CNR2 P34972 3/20 0.44
ALPL P05186 1/20 0.42
IKBKB O14920 1/20 0.40
MAP3K14 Q99558 1/20 0.40
ABL1 P00519 2/20 0.38
SRC P12931 2/20 0.38
CYP1A2 P05177 2/20 0.38
DAPK3 O43293 1/20 0.38
RIPK2 O43353 1/20 0.38
EGFR P00533 1/20 0.38
LCK P06239 1/20 0.38
FYN P06241 1/20 0.38
YES1 P07947 1/20 0.38
LYN P07948 1/20 0.38
HCK P08631 1/20 0.38
PDGFRB P09619 1/20 0.38
FGR P09769 1/20 0.38
CYP2C9 P11712 1/20 0.38
PDGFRA P16234 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5748863 0.87 MEN1 (0.42) ABL1SRCCYP1A2RIPK2EGFR
SCHEMBL7515835 0.86 CLK4 (0.42) CNR1CNR2ALPLABL1SRC
SCHEMBL7826933 0.80 IKBKB (0.46) CNR1CNR2ALPLIKBKBABL1
SCHEMBL6055066 0.78 KDM4E (0.50) ABL1SRCEGFRHCKKDR
SCHEMBL1270137 0.77 ABL1 (0.57) CNR1CNR2ALPLIKBKBMAP3K14
SCHEMBL3715031 0.75 SRC (0.57) ALPLIKBKBMAP3K14ABL1SRC
SCHEMBL13020474 0.74 IKBKB (0.44) ALPLIKBKBMAP3K14ABL1SRC
SCHEMBL8402143 0.72 BTK (0.55) BTKTNK2
SCHEMBL5088174 0.69 PIK3CD (0.60) ABL1SRCCYP1A2DAPK3RIPK2
SCHEMBL14735752 0.69 PRKACA (0.44) CNR1ALPLABL1SRCCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482983-A4 NON-MYELOABLATIVE TOLEROGENIC TREATMENT WITH TYRPHOSTINS YISSUM RES DEV CO (IL) 2006-07-12 EP claimed
EP-1482983-A2 NON-MYELOABLATIVE TOLEROGENIC TREATMENT WITH TYRPHOSTINS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-12-08 EP claimed
WO-2003065971-A2 NON-MYELOABLATIVE TOLEROGENIC TREATMENT WITH TYRPHOSTINS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2003-08-14 WO claimed
EP-3303566-A2 MATURATION OF MAMMALIAN HEPATOCYTES Takara Bio Europe AB (SE) 2018-04-11 EP disclosed
WO-2016193441-A2 MATURATION OF MAMMALIAN HEPATOCYTES TAKARA BIO EUROPE AB (SE) 2016-12-08 WO disclosed
WO-2011014239-A1 ANTI-PROLIFERATIVE SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDINES DERIVATIVES (SPP) TO INHIBIT IMMUNE ACTIVATION, VIRUS REPLICATION AND TUMOR GROWTH VIROSTATICS SRL (IT) 2011-02-03 WO disclosed